Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model
about
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine modelReceptor-mediated enhancement of beta adrenergic drug activity by ascorbate in vitro and in vivoβ-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational StudyEvidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.Alteration of airway responsiveness mediated by receptors in ovalbumin-induced asthmatic E3 rats.Repeated bouts of moderate-intensity aerobic exercise reduce airway reactivity in a murine asthma model.Sorafenib cardiotoxicity increases mortality after myocardial infarction.Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.For the love of paradox: from neurobiology to pharmacologyDefective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe AsthmaEffects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.β-Blockers have differential effects on the murine asthma phenotype.Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.Beta-blockers: friend or foe in asthma?β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocolAgonizing over agonism: should asthmatics turn their beta-receptors on or off?β2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.beta-Adrenoceptor inverse agonists in asthmaβ-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.Current treatment of severe asthma.β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.Ligand bias prevents class equality among beta-blockers.Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.Think the impossible: beta-blockers for treating asthma.The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells.The role of beta-blockers in the management of chronic obstructive pulmonary disease.Use of Cardioselective ß-Blockers in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized, Placebo-controlled, Blinded Trials
P2860
Q24646260-B9F6BE14-9186-4C49-84CA-6D4303EBB709Q28476500-43F7E3FF-98A6-4896-B80E-A1BE350979D6Q28533991-AE86D366-EB6E-48CC-9251-7D717F45E81EQ33552609-F55D8493-5E79-44F0-AD60-3EB1548AD408Q33552676-1A3D4141-E34A-4295-ADE0-448055FCE642Q33658845-23FCAEA5-85B3-4A6A-8326-8D903792F3BFQ33681995-743C7927-8E43-4829-8FB5-ADC5BD8DF1B0Q33792699-8DED34AB-6FAF-4D35-8459-8F357C14BCD0Q34575920-45D56B76-EE4C-4B0A-8CDD-F40673E344E7Q35163044-3464736C-A12B-4455-A162-F6CACF3D8903Q35645970-019FB9A9-6B29-433C-A542-F9D1AD722EEDQ36111202-A91E1CB0-980A-4B11-9F10-76C284BE797BQ36211207-2708FF8F-AB61-408D-B872-EF6311EC7EFCQ36482653-79A5C1A7-9685-47D9-A25D-0D803C3D950BQ36703892-1E64EA43-FF05-442B-8B4E-3AAE56189522Q37006857-37288EA1-4834-494E-8BF7-562BE5E5A37BQ37006972-19E29135-FDC5-4144-AD06-8DFA1C381921Q37114730-0636F353-68EE-451F-984E-DA8ACB1A65DBQ37554447-1F5C56A9-3A4A-42FB-97DF-AB92F58D42BEQ37732847-F2DAEE4E-C991-418D-9114-58CA72A9F23DQ37822723-E485AB48-4F56-444A-973C-A2635DB84B1BQ37822833-F3848D5B-E3F1-4357-8A19-57A1FB927E96Q37976485-4F042517-ADF1-4F01-9416-706897E8A94CQ38152743-0C3D9947-D4A2-4448-B47C-A9F8F08A2446Q38200427-B6668928-1C09-4FE0-94D4-69A88BECA40CQ38224810-04A38D60-A2BB-4614-8F8D-8BB22C41BF75Q38871993-460BEB22-1DF9-4F19-B28B-88E2EE034CEEQ39297594-3F402F98-AE6C-4F30-AE18-38E6FE00B84DQ42482442-80B199FB-F7BE-42DB-9A7F-9653D4FC3C92Q47676572-605261C6-0180-4015-BDDA-BCFB2FC02B6AQ55981707-B1C79118-DB0B-471C-8C56-0B7929B8D2E7
P2860
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Changes in beta 2-adrenoceptor ...... kers' in a murine asthma model
@en
type
label
Changes in beta 2-adrenoceptor ...... kers' in a murine asthma model
@en
prefLabel
Changes in beta 2-adrenoceptor ...... kers' in a murine asthma model
@en
P2093
P2860
P1476
Changes in beta 2-adrenoceptor ...... kers' in a murine asthma model
@en
P2093
Brian J Knoll
Felix Shardonofsky
Long P Nguyen
Noor B Dudekula
Richard A Bond
Sergio Parra
P2860
P304
P356
10.1016/J.PUPT.2007.06.003
P577
2007-07-04T00:00:00Z